Nom |
Miglustat |
Nom anglais |
Miglustat; (2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol; 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2R,3R,4R,5S)-; BuDNJ; Butyldeoxynojirimycin; N-(n-Butyl)deoxynojirimycin; N-Butyldeoxynojirimycin; N-Butylmoranoline; N-butyl-1-deoxynojirimycin; NB-DNJ; OGT 918; SC 48334; SC-48334; SC48334; UNII-ADN3S497AZ; Zavesca; n-Butyl deoxynojirimycin; n-Butyl dnj; 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-; D-Glucitol, 1,5-(butylimino)-1,5-dideoxy-; hydrogen chloride (2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol (1:1:1) |
Formule moléculaire |
C10H22ClNO4 |
Poids Moléculaire |
255.739 |
InChI |
InChI=1/C10H21NO4.ClH/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12;/h7-10,12-15H,2-6H2,1H3;1H/t7-,8+,9-,10-;/m1./s1 |
Numéro de registre CAS |
72599-27-0 |
Structure moléculaire |
|
Point d'ébullition |
394.7°C at 760 mmHg |
Point d'éclair |
215.4°C |
Pression de vapeur |
7.27E-08mmHg at 25°C |
Les symboles de danger |
|
Codes des risques |
|
Description de sécurité |
|
|